Dr. Lisa H. Lancaster, MD

Dr. Lancaster practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Lancaster's NPI, 1144312562, was assigned on September 30, 2006. Dr. Lancaster graduated from Medical College of Georgia in 1993. Dr. Lancaster holds Tennessee license MD28678.

Dr. Lancaster's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Lancaster's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Lancaster to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lancaster practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Lancaster's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Lancaster is board certified in pulmonary disease by the American Board of Internal Medicine. Dmand AI has Dr. Lancaster's licenses on file in 2 states: Tennessee and Alabama.

Dmand AI lists chronic lung disease, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, collapsed lung, lung disease: COPD, asthma or bronchitis, pneumonia and respiratory infection, pulmonary fibrosis and sleep apnea among the conditions Dr. Lancaster treats.

CMS data shows 765 Medicare services from Dr. Lancaster across 12 procedure codes in 2024, for 288 Medicare patients. Medicare paid $24,980 for them.

CMS counts 288 Medicare patients who saw Dr. Lancaster in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lancaster's median patient age at 71, with 50% women.

In 2024, Dr. Lancaster wrote 242 Medicare Part D claims for 57 patients. 47% of them were for generic drugs. CMS names the drug for 141 of them, across 5 drugs with 11 or more claims each, at $615,197 in total drug cost. In 2023, CMS named 208 claims across 8 drugs.

Dr. Lancaster accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lancaster as offering telehealth.

Dmand AI links 54 papers to Dr. Lancaster, published from 2007 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Idiopathic Pulmonary Fibrosis, Vital Capacity and Pyridones. Dr. Lancaster has published most often in Am J Respir Crit Care Med. Dr. Lancaster's most frequent co-authors are Paul Wesley Noble, MD, Talmadge Everett King, MD and Kevin Robert Flaherty, MD.

Dmand AI links Dr. Lancaster to 6 clinical trials, 4 of them phase 2 studies. 2 are still active or recruiting. Conditions studied include Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis and Idiopathic Interstitial Pneumonias. Open Payments lists research payments to Dr. Lancaster that name 1 trial.

CMS Open Payments shows 770 general payments to Dr. Lancaster from 17 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. Genentech, Inc. paid the most, $385,171. It also lists 23 research payments totaling $19,972 from 2018 to 2025, naming 1 clinical trial.

Dmand AI lists 3 awards for Dr. Lancaster, most recently Nashville Lifestyles Magazine in 2014.

Dr. Lancaster graduated from Medical College of Georgia in 1993.

Dr. Lancaster is in network with 18 carriers, including Elevance, Cigna and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.